NCT Number: NCT07085364
This study will be a pilot randomized controlled trial, to investigate the effectiveness of an external focus training on visuomotor performance while comparing with an active control group.
Trial opening soon.
Get Notified65 year and older
All sexes
Interventional
Not applicable
All eligible participants will be randomly divided into two groups: external focus gait training group (EXT) and active control group (CON). All participants will complete two assessment sessions: at baseline (T0) and immediately following the completion of all training sessions (T1). A total of twelve training sessions (about 45 minutes per session), held twice a week for six weeks, would be provided to participants in both training groups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Every training session will include the following activities for both groups: a 5-minute warm-up; a 30-minute walking training; and a 5-minute cool-down. The walking training will be conducted within a level-ground walking field. Participants will be instructed to look at and step on specific markers/labels that will be attached along the walking paths.
Every training session will include the following activities for both groups: a 5-minute warm-up; a 30-minute walking training; and a 5-minute cool-down. The walking training will be conducted within a level-ground walking field. No markers/labels will be attached and no relevant instructions will be provided apart from the general instruction.
Time frame: baseline (pre-intervention), immediately after intervention (post-intervention)
measured by a 3-D motion capture system; stride time is defined as the interval between two consecutive heel strikes of the same foot; the variability measure is represented by the coefficients of variation (CV) [(standard deviation/mean) × 100]
Time frame: baseline (pre-intervention), immediately after intervention (post-intervention)
measured by a 3-D motion capture system; stride length is defined as anterior-posterior (A-P) distance between two consecutive heel strike positions of the same foot; the variability measure is represented by the coefficients of variation (CV) [(standard deviation/mean) × 100]
Time frame: baseline (pre-intervention), immediately after intervention (post-intervention)
measured by a 3-D motion capture system; step width is defined as medial-lateral (M-L) distance between two consecutive heel strike positions of the opposite feet; the variability measure is represented by the coefficients of variation (CV) [(standard deviation/mean) × 100]
Time frame: baseline (pre-intervention), immediately after intervention (post-intervention)
measured by a wireless eye tracker; recorded the location that the gaze is fixated on
Time frame: baseline (pre-intervention), immediately after intervention (post-intervention)
measured by a wireless eye tracker; recorded the number of times the gaze is fixated on each area of interest
Time frame: baseline (pre-intervention), immediately after intervention (post-intervention)
measured by a wireless eye tracker; recorded the duration that the gaze is fixated on each area of interest
Time frame: baseline (pre-intervention), immediately after intervention (post-intervention)
measured by the Tinetti Balance Assessment Tool; min: 0; max: 28; higher scores reflect better functional balance and gait
Time frame: baseline (pre-intervention), immediately after intervention (post-intervention)
measured by the Chinese version of the Falls Efficacy Scale International; min: 16; max: 64; higher scores reflect greater concern about falling
Time frame: baseline (pre-intervention), immediately after intervention (post-intervention)
measured by the Chinese version of the Movement Specific Reinvestment Scale; min: 10, max: 60; higher scores reflect higher propensity for conscious movement processing
Time frame: baseline (pre-intervention), immediately after intervention (post-intervention)
measured by the Berg Balance Scale; min: 0; max: 56; higher scores reflect better functional balance
Time frame: baseline (pre-intervention), immediately after intervention (post-intervention)
measured by the Timed 'Up & Go' Test (in seconds); a longer time to complete reflects poorer functional mobility
The Hong Kong Polytechnic University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07625878
Attention, Gait
Dokki, Giza Governorate, Egypt
View Trial DetailsNCT06571526
Fall Risk, Gait
Hong Kong
View Trial DetailsNCT07689227
Central Nervous System Diseases, Functional Mobility
Boston, Massachusetts, United States
View Trial DetailsNCT07578740
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Ankara, Turkey (Türkiye)
View Trial Details